{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:09:38Z","timestamp":1781680178511,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["HHSS28342005T"],"award-info":[{"award-number":["HHSS28342005T"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["HHSS283201200006I"],"award-info":[{"award-number":["HHSS283201200006I"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.addbeh.2019.106268","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T16:46:33Z","timestamp":1577205993000},"page":"106268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The impact of the abuse-deterrent reformulation of extended-release OxyContin on prescription pain reliever misuse and heroin initiation"],"prefix":"10.1016","volume":"105","author":[{"given":"Carolyn","family":"Wolff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandler","family":"McClellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Meinhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Glos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Mutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2019.106268_b0005","unstructured":"Administration FaD. (2018). Healthy innovation, safer families: FDA's 2018 strategic policy roadmap. Silver Spring, MD."},{"key":"10.1016\/j.addbeh.2019.106268_b0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addbeh.2017.01.011","article-title":"Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health","volume":"69","author":"Ali","year":"2017","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.addbeh.2019.106268_b0015","first-page":"1","article-title":"Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids","volume":"10","author":"Alpert","year":"2018","journal-title":"American Economic Journal: Economic Policy"},{"key":"10.1016\/j.addbeh.2019.106268_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jhealeco.2016.12.009","article-title":"Economic conditions, illicit drug use, and substance use disorders in the United States","volume":"52","author":"Carpenter","year":"2017","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.addbeh.2019.106268_b0025","unstructured":"American Psychiatric Association. (1994). DSM-IV: Diagnostic and statistical manual. Washington, DC: American Psychiatric Association."},{"key":"10.1016\/j.addbeh.2019.106268_b0030","first-page":"358","article-title":"Limited evidence, faulty reasoning, and potential for a global opioid crisis","author":"Becker","year":"2017","journal-title":"BMJ: British Medical Journal (Online)"},{"issue":"24","key":"10.1016\/j.addbeh.2019.106268_b0035","first-page":"1","article-title":"Estimating policy and program effects with observational data: The \u201cdifferences-in-differences\u201d estimator","volume":"8","author":"Buckley","year":"2003","journal-title":"Practical Assessment, Research & Evaluation"},{"issue":"2","key":"10.1016\/j.addbeh.2019.106268_b0040","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/17450121003615351","article-title":"Evaluating the impact of community-based interventions on schooling outcomes among orphans and vulnerable children in Lusaka, Zambia","volume":"5","author":"Chatterji","year":"2010","journal-title":"Vulnerable Children and Youth Studies"},{"issue":"4","key":"10.1016\/j.addbeh.2019.106268_b0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpain.2012.08.008","article-title":"Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment","volume":"14","author":"Butler","year":"2013","journal-title":"The Journal of Pain"},{"issue":"3","key":"10.1016\/j.addbeh.2019.106268_b0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2019.106268_b0055","unstructured":"Center for Disease Control and Prevention NCfIPaC, Division of Unintentional Injury Prevention. Opioid Data Analysis. Accessed 5\/21\/2018, 2017."},{"issue":"5","key":"10.1016\/j.addbeh.2019.106268_b0060","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/jamapsychiatry.2014.3043","article-title":"Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: Lessons learned from OxyContin","volume":"72","author":"Cicero","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.addbeh.2019.106268_b0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1204141","article-title":"Effect of abuse-deterrent formulation of OxyContin","volume":"367","author":"Cicero","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2019.106268_b0070","unstructured":"Opioid Abuse Deterrence, Research, and Recovery Act of 2017 (2017)."},{"issue":"2","key":"10.1016\/j.addbeh.2019.106268_b0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.addbeh.2019.106268_b0080","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/pds.3522","article-title":"Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics","volume":"22","author":"Coplan","year":"2013","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"15","key":"10.1016\/j.addbeh.2019.106268_b0085","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.addbeh.2019.106268_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/rest_a_00755","article-title":"How the reformulation of oxycontin ignited the heroin epidemic","volume":"101","author":"Evans","year":"2019","journal-title":"Review of Economics and Statistics"},{"key":"10.1016\/j.addbeh.2019.106268_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2014.02.018","article-title":"The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers","volume":"139","author":"Havens","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.addbeh.2019.106268_b0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/jae.1269","article-title":"Measuring the effect of napster on recorded music sales: Difference-in-differences estimates under compositional changes","volume":"28","author":"Hong","year":"2013","journal-title":"Journal of Applied Econometrics"},{"key":"10.1016\/j.addbeh.2019.106268_b0105","first-page":"A1","article-title":"Prescription drug use and misuse in the United States: Results from the 2015 National Survey on Drug Use and Health","author":"Hughes","year":"2016","journal-title":"NSDUH Data Review"},{"issue":"1","key":"10.1016\/j.addbeh.2019.106268_b0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2013United States, 2002\u20132004 and 2008\u20132010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2019.106268_b0115","doi-asserted-by":"crossref","unstructured":"US Department of Health and Human Services (2015). Opioid abuse in the US and HHS actions to address opioid-drug related overdoses and deaths.","DOI":"10.3109\/15360288.2015.1037530"},{"issue":"5","key":"10.1016\/j.addbeh.2019.106268_b0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/AJP.0000000000000426","article-title":"Trends in the nonmedical use of OxyContin, United States, 2006 to 2013","volume":"33","author":"Jones","year":"2017","journal-title":"The Clinical Journal of Pain"},{"key":"10.1016\/j.addbeh.2019.106268_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2018.03.014","article-title":"Opioid-overdose laws association with opioid use and overdose mortality","author":"McClellan","year":"2018","journal-title":"Addictive Behaviors"},{"issue":"11","key":"10.1016\/j.addbeh.2019.106268_b0130","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1176\/appi.ps.201500538","article-title":"Prescriptions filled following an opioid-related hospitalization","volume":"67","author":"Naeger","year":"2016","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.addbeh.2019.106268_b0135","unstructured":"OXYCONTIN (oxycodone hydrochloride) extended-release tablet [package insert], Purdue Pharma L.P., Stamford, CT. 2017:28."},{"key":"10.1016\/j.addbeh.2019.106268_b0145","unstructured":"RTI International. (2015). 2014 National Survey on Drug Use and Health Methodological Summary and Definitions. Available at https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-MethodSummDefs2014\/NSDUH-MethodSummDefs2014.htm."},{"key":"10.1016\/j.addbeh.2019.106268_b0150","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration. Available at http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FRR1-2014\/NSDUH-FRR1-2014.pdf."},{"issue":"1","key":"10.1016\/j.addbeh.2019.106268_b0155","doi-asserted-by":"crossref","first-page":"1327241","DOI":"10.1080\/16549716.2017.1327241","article-title":"The effect of performance-based financing on maternal healthcare use in Burundi: A two-wave pooled cross-sectional analysis","volume":"10","author":"Rudasingwa","year":"2017","journal-title":"Global Health Action"},{"key":"10.1016\/j.addbeh.2019.106268_b0160","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ajt.13776","article-title":"Increases in drug and opioid overdose deaths-United States, 2000\u20132014","volume":"4","author":"Rudd","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1016\/j.addbeh.2019.106268_b0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pam.22047","article-title":"Ending the opioid epidemic requires a historic investment in medication-assisted treatmeNT","volume":"37","author":"Saloner","year":"2018","journal-title":"Journal of Policy Analysis and Management"},{"issue":"12","key":"10.1016\/j.addbeh.2019.106268_b0170","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/pds.3658","article-title":"Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation","volume":"23","author":"Sessler","year":"2014","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.addbeh.2019.106268_b0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2016.09.018","article-title":"Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone","volume":"168","author":"Severtson","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.addbeh.2019.106268_b0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.2018.0058","article-title":"A new year\u2019s wish on opioids","volume":"319","author":"Sharfstein","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.addbeh.2019.106268_b0185","unstructured":"Stata Statistical Software: Release 14 [computer program]. (2015). Version. College Station, TX."},{"key":"10.1016\/j.addbeh.2019.106268_b0190","unstructured":"Substance Abuse and Mental Health Services Administration. (2016). Key substance use and mental health indicators in the United States: Results from the 2015 national survey on drug use and health. Rockville, MD: Substance Abuse and Mental Health Services Administration. Available at https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FFR1-2015\/NSDUH-FFR1-2015\/NSDUH-FFR1-2015.pdf."},{"key":"10.1016\/j.addbeh.2019.106268_b0195","unstructured":"United States Census Bureau. (2015). 2010 Census Urban and Rural Classification and Urban Area Criteria. Available at https:\/\/www.census.gov\/geo\/reference\/ua\/urban-rural-2010.html."}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460319310287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460319310287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:40:04Z","timestamp":1759689604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460319310287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"alternative-id":["S0306460319310287"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2019.106268","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of the abuse-deterrent reformulation of extended-release OxyContin on prescription pain reliever misuse and heroin initiation","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2019.106268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106268"}}